MercoPress, en Español
Montevideo, April 19th 2025 - 07:00 UTC
Brazil's Fiocruz biomedical institute will seek approval for the Oxford University/AstraZeneca vaccine against COVID-19 with federal health regulator Anvisa on Jan. 15, one of the center's senior officials said on Monday.
Get our news on your inbox! Suscribe